期刊文献+

呼吸道合胞病毒单克隆抗体逃逸株体内适合度研究 被引量:1

In vivo fitness of respiratory syncytial virus Palivizumab escape mutants
原文传递
导出
摘要 目的此前研究已在体外筛选获得呼吸道合胞病毒(RSV) Palivizumab(PZ)逃逸株MP4,体外评估发现MP4适合度高于A2母株,本研究在免疫缺陷棉鼠模型中进一步评价MP4体内适合度。方法采用大剂量环磷酰胺腹腔注射法制备免疫抑制鼠模型,将PZ逃逸株MP4和母株A2等量混合,经鼻腔接种免疫缺陷动物模型,于接种后4天和4周分批处死动物,取动物肺脏组织研磨后采用差异噬斑形成法或核苷酸序列图谱分析法检测混合病毒群体中母株A2和逃逸株MP4的相对含量,以代表MP4相对于A2的适合度。将肺内病毒F基因片段RT—PCR扩增产物克隆并转化大肠杆菌,随机挑取部分菌落再行PCR扩增F基因片段及序列测定,观察F基因第828位碱基并计算A2株和MP4相对含量。结果差异噬斑法结果显示接种后4天和4周棉鼠肺内病毒混合群体中均以MP4占优,序列图谱分析发现接种后4周8只棉鼠中7只肺内MP4占优。接种后4周克隆的8只棉鼠F基因片段78%(120/154)为MP4基因信号。结论与体外适合度结果类似,MP4在棉鼠肺内的适合度高于A2母株,提示与MP4基因型相同的逃逸株一旦产生,可能在免疫缺陷个体间传播。 Objective To assess the fitness of the Palivizumab(PZ)-resistant respiratory syncytial virus(RSV) stain MP4 in cotton rat lung in vivo. Methods The mixture was made with equal amounts of A2 and MP4 virus and inoculated to immunosuppressed cotton rats which had been treated with cyclophos- phamide. At day 4 and week 4 post inoculation, animals were sacrificed and lungs were harvested for virus titration by differential plaque assay and nueleotide sequence analysis. The F gene fragments were amplified by RT-PCR and cloned into the plasmid, then transformed E. coll. Certain amount of colonies were picked for same F gene fragment amplification, and PCR products were sequenced for A2 or MP4 signal at nucleo- tide 828. Relative amount of MP4 in the mixed viral population were then calculated. Results MP4 pre- dominated in cotton rat lungs either by differential plaque assay or nucleotide sequence analysis at week 4 post inoculation, although the viral population consisted of more complicated viruses. Among the total 154 analyzed F gene clones, the majority (120) contained MP4 gene signal. Conclusion The mutant MP4 vi- rus is of more fitness than parental A2 virus in cotton rat lungs, similar to that seen in vitro fitness assess- ment. Mutant viruses with similar resistance to PZ and increased fitness are more likely to disseminate in the population, particularly in immunocomprimised individuals.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2009年第1期58-61,共4页 Chinese Journal of Microbiology and Immunology
基金 基金项目:美国National Institutes of Health研究基金资助(R01A146495)
关键词 呼吸道合胞病毒 逃逸株 适合度 竞争复制 动物模型 Respiratory syncytial virus Escape mutant Fitness Competitive replication Animal model
  • 相关文献

参考文献10

  • 1IMPACT-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics, 1998, 102(3) : 531-537.
  • 2Morse S. The evolutionary biology of viruses. New York: Raven Press, 1994: 161-184.
  • 3赵晓东,杨锡强,陈坤华.呼吸道合胞病毒逃逸株对单克隆抗体预防的抵抗[J].中华微生物学和免疫学杂志,2005,25(3):222-226. 被引量:5
  • 4赵晓东,W.Sullender,杨锡强.呼吸道合胞病毒单克隆抗体抵抗株的体内筛选[J].重庆医科大学学报,2006,31(1):5-9. 被引量:2
  • 5赵晓东,刘恩梅,W. Sullender.呼吸道合胞病毒单克隆抗体逃逸株体外适合度变化[J].中华微生物学和免疫学杂志,2008,28(12):1103-1106. 被引量:2
  • 6Holland JJ, De La Torre JC, Clarke DK, et al. Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses. J Virol, 1991, 65(6) : 2960-2967.
  • 7Johnson RA, Prince GA, Suffin SC, et al. Respiratory syncytial virus infection in cyclophosphamidetreated cotton rats. Infect Immun, 1982, 37(1) : 369-373.
  • 8Ellis GM, Mahalanabis M, Beck IA, et al. Comparison of oligonucleotide ligation assay and consensus sequencing for detection of drug-resistant mutants of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and plasma. J Clin Microbiol, 2004, 42(8): 3670-3674.
  • 9Martinez-Picado J, Prado JG, Fry EE, et al. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol, 2006, 80(7) : 3617-3623.
  • 10DeVincenzo JP, Hall CB, Kimberlin DW, et al. Surveillance of clinical isolates of respiratory syncytial virus for palivizumab ( Synagis)-resistant mutants. J Infect Dis, 2004, 190(5 ) : 975-978.

二级参考文献45

  • 1赵晓东,杨锡强,陈坤华.呼吸道合胞病毒逃逸株对单克隆抗体预防的抵抗[J].中华微生物学和免疫学杂志,2005,25(3):222-226. 被引量:5
  • 2赵晓东,W.Sullender,杨锡强.呼吸道合胞病毒逃逸株对单克隆抗体预防的抗性比较[J].中华微生物学和免疫学杂志,2005,25(8):648-651. 被引量:5
  • 3赵晓东,W.Sullender,杨锡强.呼吸道合胞病毒单克隆抗体抵抗株的体内筛选[J].重庆医科大学学报,2006,31(1):5-9. 被引量:2
  • 4Shann F, Steinhoff MC. Vaccines for children in rich and poor countries. Lancet, 1999, 354 Suppl 2: SⅡ7-11.
  • 5IMPACT-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998, 102(3) : 531-537.
  • 6Morse S. The evolutionary biology of viruses. New York: Raven Press, 1994: 161-184.
  • 7Ellis GM, Mahalanabis M, Beck IA, et al. Comparison of oligonueleotide ligation assay and consensus sequencing for detection of drug-resistant mutants of human immunodeficiency virus type 1 in peripheral blood mononuelear cells and plasma. J Clin Microbiol, 2004, 42(8) : 3670-3674.
  • 8Lahser FC, Wright-Minogue J, Skehon A, et al. Quantitative estimation of viral fitness using Pyrosequencing. BioTechniques, 2003, 34 ( 1 ) : 26-28.
  • 9Novella IS, Ball LA, Wertz GW. Fitness analyses of vesicular stomatitis strains with rearranged genomes reveal replicative disadvantages. J Virol, 2004, 78 (18) : 9837-9841.
  • 10Peret T, Hall C, Hammond G, et al. Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis, 2000, 181(6) : 1891-1896.

共引文献5

同被引文献33

  • 1范行良,周铁群.呼吸道合胞病毒F蛋白研究进展[J].微生物学免疫学进展,2004,32(4):73-76. 被引量:9
  • 2芦起,申昆玲,张燕,刘亚谊,赵宇红,刘春艳,姬奕新,谢正德,许文波.北京地区呼吸道合胞病毒分离株F蛋白基因序列分析[J].首都医科大学学报,2005,26(5):565-567. 被引量:3
  • 3I Nair H, Nokes D J, Gessner B D, Dherani M, Madhi S A, Singleton R J, OBrien K L, Roca A, Wright P F, Bruce N, Chandran A, Theodoratou E, Sutanto A, Sedyaningsih E R, Ngama M, Munywoki P K, Kar- tasasmita C, SimOes E A, Rudan I, Weber M W, Campbell H. Global burden of acute lower respiratory infections due to respiratory syneytial virus in young children: a systematic review and meta--analysis[J]. Lancet, 2010,375(9725) : 1545-1555.
  • 4Tran D N, PhamT M, HaMT, TranT T, Dang T K, Yoshida L M, Okitsu S, Hayakawa S, Mizuguchi M, Ushijima H. Molecular epidemiology and disease severi- ty of human respiratory syncytial virus in Vietnam [J/ OL]. PLoS One,2013,8(1) : 45436-45446.
  • 5Kim Y K, Choi E H, Lee H J. Genetic variability of the fusion protein and circulation patterns of genotypes of the respiratory syncytial virus [J]. J Med Virol, 2007, 79(6): 820-828.
  • 6Chi H, Liu H F, Weng L C, Wang N Y, Chiu N C, Lai M J, Lin Y C, Chiu Y Y, Hsieh W S, Huang L M. Molecular epidemiology and phylodynamics of the human respiratory syncytial virus fusion protein in northern Taiwan[J/OL]. PLoS One, 2013, 8(5): 64012-64021.
  • 7Xia Q, Zhou L, Peng C, Hao R, Ni K, Zang N, Ren L, Deng Y, Xie X, He L, Tian D, Wang L, Huang A, Zhao Y, Zhao X, Fu Z, Tu W, Liu E. Detection of re- spiratory syncytial virus fusion protein variants between 2009 and 2012 in China[J]. Arch Virol, 2014, 159(5) : 1089-1098.
  • 8Sun Z, Pan Y, Jiang S, Lu L. Respiratory syncytial virus entry inhibitors targeting the F protein[J]. Viru- ses, 2013, 5(1) :211-225.
  • 9Mclellan J S, Ray W C, Peeples M E. Structure and function of respiratory syncytial virus surface glycopro- teins[J]. Curr Top Microbiol Immunol, 2013, 372:83- 104.
  • 10Beeler J A, van Wyke C K. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function[J]. J Virol, 1989, 63 (7) : 2941-2950.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部